Shop

Placeholder

Open Abdomen Treatment Market – Industry Analysis, Growth, Share, Market, 2015-2023

SKU_SAC3450
Published Date: 11/3/2017
Number of Pages: 115
Single User License $4,495.00
Multil User License $6,495.00
Global User License $8,495.00

Product Description

Open abdomen or laparostomy is a condition where the abdominal incision has been deliberately left open to promote the management of the underlying disease, or to prevent the development of intra-abdominal hypertension (IAH) and its clinically significant extreme form, the abdominal compartment syndrome(ACS). it is estimated that approximately 5 million Americans have an open abdominal wall hernia. Moreover, in the United States, approximately 175,000 open abdominal procedures (Temporary Abdomen Closure) each year at a cost of $2.5 to $3 billion annually. However, in the past two decades, numerous changes have occurred in the science of abdominal management. There has been pronounced advancements in the development of Negative Pressure Therapy (NPT) that possess rapid healing properties compared to traditional abdominal closure methods such as with clips and clamps, zipper, among the others. At present, owing to the rigorous research and development activities along with positive outcomes of clinical trials, players operating in this market have been successful in developing advanced and cost effective wound products such as abdominal dressing and, Negative pressure wound therapy (NPWT) devices, and biologics among others that provide better wound healing care and faster recovery.

The Open Abdomen Treatment Market is majorly segmented into 2 major categories that include temporary abdomen closure, and definitive abdominal closure. The market for open abdomen treatment is more inclined towards temporary abdomen closure products. The global open abdomen treatment market was valued at $XX million in 2016 and is expected to reach $XX million in 2023, growing at a CAGR of XX% from 2017 to 2023.

Temporary Abdominal Closure Products
Based on product type, the market has been segmented into 7 sub categories; Towel Clips, Sutures, Abdominal Dressings, VAC and NPWT, zipper abdominal closure, Wittmann patch and Bagota Bags, and others. Temporary abdomen closure products accounted for the largest market share of approximately XX% of the wound care market in 2016. Temporary abdomen closure market was $XX million in 2015 and is expected to witness a growth rate of XX% during the forecast period from 2017 to 2023. Growing incidences of severe abdominal sepsis, increasing number of damage control surgery along with clinical competence are some of the major factors expected to boost the temporary abdomen closure market segment market in the future. Abdominal dressings were the largest product segment, which accounted for a market share of approximately XX% in 2016. Moreover, the NPWT and VAC expected to exhibit the highest growth rate of XX% during the forecast period from 2017 to 2023.

Definitive Abdominal Closure has been segmented into biologics, sutures, tissue adhesive, and others. Biologics accounted for the largest market share of approximately XX% in 2017 and are the clear segment leader in terms of market revenue among the definitive abdominal closure segment. This is due to the fact that skin substitutes are versatile (in terms of applicability and healing) and are preferred in a majority of acute care facilities for abdominal reconstruction. Moreover, xenograft biologics segment is expected to witness the fastest growth during the forecast period from 2017 to 2023, reporting a CAGR of almost XX%; owing to their faster healing rates and advances within the basic design, thereby offering a wide range of coverage. However, products such as tissue adhesives and sutures would also demonstrate an impressive growth and are expected to continue growing in the future with increasing fetal traumatic conditions, infection and other abdominal interventions.

Table of Content

Table of Contents

1 Executive Summary 8
2 Research Scope and Methodology 14
2.1 Research Scope 14
2.2 Research Methodology 16
2.2.1 Historical and Base Year Estimation, 2015–2016 17
2.2.2 Forecasting, 2017–2023 17
2.2.2.1 Special Consideration 18
2.3 Data Sources 19
2.3.1 Secondary Research Data Sources 19
2.3.2 Primary Data Sources 20
2.3.3 Respondent Profile 21
3 Market Overview 22
3.1 Key Industrial Developments 22
3.2 Global Open Abdominal Treatment Market Overview (Addressable Market Size and Growth Potential), 2012-2016 23
3.3 World Economic Outlook of Open Abdominal Treatment Market 24
3.3.1 Key Market Developments & Strategies 24
3.3.2 New Product Launches, Developments and Expansions 25
3.3.3 Acquisitions, Partnerships and Collaborations 27
3.3.4 Business Expansion and Others 28
4 Market Dynamics 31
4.1 Market Drivers 32
4.1.1 Rise in Geriatric Population to Trigger the Growth in the Market 32
4.1.2 Surge in Chronic Conditions to Enhance Market Growth 34
4.1.3 Faster Healing Times Generates Favour Among Emergency Care and ICU Staff 34
4.1.4 Increasing Patient Awareness and Healthcare Expenditure 35
4.1.5 Rise in Incidence of Severe Traumatic Injuries Promotes the Sale of Open abdomen treatment 35
4.2 Market Restraints 35
4.2.1 High Cost of Advanced Open abdomen treatment Hampering Penetration into Asian Markets 35
4.2.2 Reluctance in Accepting Novel Technologies at the Developing Countries Trauma Centres Creates a Negative Impact on Sales 36
4.2.3 Unfavourable Reimbursement Scenario to Restraint the Growth of the Global Open abdomen treatment Market 36
4.3 Market Opportunities 36
4.3.1 Focus on the Development of Combination Dressings 37
4.3.2 Investing in Emerging Economies 37
5 Global Open Abdomen Treatment Market Target Population Analysis 38
5.1 Overview 38
5.2 Indication for Open Abdomen and Temporary Abdomen Closure 38
5.3 Temporary abdominal closure 40
5.4 Types of Temporary Abdominal Closure 41
5.4.1 Towel-clipping of skin edges 41
5.4.2 Open packing of abdomen 41
5.4.3 Wittmann patch 41
5.4.4 Synthetic mesh closure 43
5.4.5 Absorbable mesh 43
5.4.6 Silastic (plastic bag) closure 43
5.4.7 Vacuum-Assisted Closure 44
6 Competitive Landscape 46
6.1 Global Market Share Analysis 46
6.1.1 Market Share Analysis 46
6.1.1.1 Acelity, Inc. 48
6.1.1.2 Smith & Nephew, Plc 48
6.1.1.3 Medline Industries, Inc. 48
6.1.2 Regional Market Share Analysis 49
6.2 Comprehensive Competitive Index 50
6.3 Opportunity Matrix Analysis 51
7 Global Open Abdomen Treatment Market by Products, 2017-2023 53
7.1 Overview 53
7.2 Temporary Abdomen Closure 55
7.2.1 Towel Clips and Mesh 56
7.2.2 Sutures 57
7.2.3 Abdominal Dressing 58
7.2.4 VAC and NPWT 59
7.2.5 zipper Abdominal Closure 61
7.2.6 Wittmann patch and Bagota Bags 62
7.2.7 Others 63
7.3 Definitive Abdominal Closure 64
7.3.1 Allograft 65
7.3.2 Xenograft 66
7.3.3 Sutures 66
7.3.4 Tissue Adhesives 67
7.3.5 Others 69
8 Global Open Abdomen Treatment Market by Geography, 2017-2023 70
8.1 North America 73
8.1.1 The U.S. 74
8.1.2 Canada 76
8.2 Europe 78
8.2.1 U.K. 79
8.2.2 Germany 81
8.3 Asia Pacific 82
8.3.1 Japan 84
8.3.2 China 85
8.4 Latin America 86
8.4.1 Brazil 86
8.4.2 Mexico 88
8.5 Middle East 88
8.5.1 Saudi Arabia (KSA) 89
8.5.2 United Arab Emirates (UAE) 90
8.6 RoW 91
9 Company Profiles 92
9.1 3M Healthcare 92
9.1.1 Overview 92
9.1.2 Financials 92
9.1.2.1 Financial Summary 95
9.1.3 SWOT Analysis 96
9.2 Acelity (Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited) 97
9.2.1 Overview 97
9.2.2 Financials 98
9.2.2.1 Financial Summary 100
9.2.3 SWOT Analysis 101
9.3 B. Braun Melsungen AG 102
9.3.1 Overview 102
9.3.2 Financials 103
9.3.2.1 Financial Summary 105
9.3.3 SWOT Analysis 106
9.4 Coloplast A/S 107
9.4.1 Overview 107
9.4.2 Financials 107
9.4.2.1 Financial Summary 110
9.4.3 SWOT Analysis 111
9.5 ConvaTec, Inc. 112
9.5.1 Overview 112
9.5.2 Financials 113
9.5.2.1 Financial Summary 115
9.5.3 SWOT Analysis 116
9.6 Derma Sciences, Inc. 117
9.6.1 Overview 117
9.6.2 Financials 118
9.6.2.1 Financial Summary 120
9.6.3 SWOT Analysis 121
9.7 Paul Hartmann AG 122
9.7.1 Overview 122
9.7.2 Financials 123
9.7.2.1 Financial Summary 125
9.7.3 SWOT Analysis 126
9.8 Smith & Nephew 127
9.8.1 Overview 127
9.8.2 Financials 128
9.8.2.1 Financial Summary 130
9.8.3 SWOT Analysis 131
9.9 Medline Industries, Inc. 132
9.9.1 Overview 132
9.1 Molnlycke Health Care 133
9.10.1 Overview 133
9.11 Vivostat A/S 134
9.11.1 Overview 134
9.12 MediPurpose 135
9.12.1 Overview 135

Search Reports

Top